A Phase 2 Randomized, Double-Masked, Placebo-Controlled Study of a Novel Integrin Antagonist (SAR 1118) for the Treatment of Dry Eye

2012107 citationsJournal Article

Authors

Good health and well-being

Published in: American Journal of Ophthalmology

Volume 153, Issue 6, pp. 1050-1060.e1

Field-Weighted Citation Impact: 6.91